These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2537428)

  • 21. Novel stable camptothecin derivatives replacing the E-ring lactone by a ketone function are potent inhibitors of topoisomerase I and promising antitumor drugs.
    Lansiaux A; Léonce S; Kraus-Berthier L; Bal-Mahieu C; Mazinghien R; Didier S; David-Cordonnier MH; Hautefaye P; Lavielle G; Bailly C; Hickman JA; Pierré A
    Mol Pharmacol; 2007 Aug; 72(2):311-9. PubMed ID: 17494837
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Review camptothecin: current perspectives.
    Li QY; Zu YG; Shi RZ; Yao LP
    Curr Med Chem; 2006; 13(17):2021-39. PubMed ID: 16842195
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plant antitumor agents. 23. Synthesis and antileukemic activity of camptothecin analogues.
    Wani MC; Nicholas AW; Wall ME
    J Med Chem; 1986 Nov; 29(11):2358-63. PubMed ID: 3783593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and cytotoxic activity of new 9-substituted camptothecins.
    Dallavalle S; Rocchetta DG; Musso L; Merlini L; Morini G; Penco S; Tinelli S; Beretta GL; Zunino F
    Bioorg Med Chem Lett; 2008 May; 18(9):2781-7. PubMed ID: 18434153
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and biological evaluation of 10,11-methylenedioxy-14-azacamptothecin.
    Elban MA; Sun W; Eisenhauer BM; Gao R; Hecht SM
    Org Lett; 2006 Aug; 8(16):3513-6. PubMed ID: 16869648
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
    Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
    Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel hexacyclic camptothecin derivatives. Part 1: synthesis and cytotoxicity of camptothecins with an A-ring fused 1,3-oxazine ring.
    Wang S; Li Y; Liu Y; Lu A; You Q
    Bioorg Med Chem Lett; 2008 Jul; 18(14):4095-7. PubMed ID: 18554906
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new strategy to improve the metabolic stability of lactone: discovery of (20S,21S)-21-fluorocamptothecins as novel, hydrolytically stable topoisomerase I inhibitors.
    Miao Z; Zhu L; Dong G; Zhuang C; Wu Y; Wang S; Guo Z; Liu Y; Wu S; Zhu S; Fang K; Yao J; Li J; Sheng C; Zhang W
    J Med Chem; 2013 Oct; 56(20):7902-10. PubMed ID: 24069881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential effects of the poly (ADP-ribose) polymerase (PARP) inhibitor NU1025 on topoisomerase I and II inhibitor cytotoxicity in L1210 cells in vitro.
    Bowman KJ; Newell DR; Calvert AH; Curtin NJ
    Br J Cancer; 2001 Jan; 84(1):106-12. PubMed ID: 11139322
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Camptothecin analogues with enhanced antitumor activity at acidic pH.
    Adams DJ; Dewhirst MW; Flowers JL; Gamcsik MP; Colvin OM; Manikumar G; Wani MC; Wall ME
    Cancer Chemother Pharmacol; 2000; 46(4):263-71. PubMed ID: 11052623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives.
    Rivory LP; Robert J
    Pharmacol Ther; 1995; 68(2):269-96. PubMed ID: 8719971
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plant antitumor agents. 30. Synthesis and structure activity of novel camptothecin analogs.
    Wall ME; Wani MC; Nicholas AW; Manikumar G; Tele C; Moore L; Truesdale A; Leitner P; Besterman JM
    J Med Chem; 1993 Sep; 36(18):2689-700. PubMed ID: 8410981
    [TBL] [Abstract][Full Text] [Related]  

  • 33. On the mechanism of topoisomerase I inhibition by camptothecin: evidence for binding to an enzyme-DNA complex.
    Hertzberg RP; Caranfa MJ; Hecht SM
    Biochemistry; 1989 May; 28(11):4629-38. PubMed ID: 2548584
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of COMPARE analysis to discover new natural product drugs: isolation of camptothecin and 9-methoxycamptothecin from a new source.
    Zhou BN; Hoch JM; Johnson RK; Mattern MR; Eng WK; Ma J; Hecht SM; Newman DJ; Kingston DG
    J Nat Prod; 2000 Sep; 63(9):1273-6. PubMed ID: 11000035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin.
    Tangirala RS; Antony S; Agama K; Pommier Y; Anderson BD; Bevins R; Curran DP
    Bioorg Med Chem; 2006 Sep; 14(18):6202-12. PubMed ID: 16793274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recent advances in topoisomerase I-targeting agents, camptothecin analogues.
    Kim DK; Lee N
    Mini Rev Med Chem; 2002 Dec; 2(6):611-9. PubMed ID: 12370044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of novel A-ring modified hexacyclic camptothecin analogues.
    Kim DK; Ryu DH; Lee JY; Lee N; Kim YW; Kim JS; Chang K; Im GJ; Kim TK; Choi WS
    J Med Chem; 2001 May; 44(10):1594-602. PubMed ID: 11334569
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacology of camptothecin and its derivatives].
    Rivory LP; Robert J
    Bull Cancer; 1995 Apr; 82(4):265-85. PubMed ID: 10846537
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and biological evaluation of novel homocamptothecins conjugating with dihydropyrimidine derivatives as potent topoisomerase I inhibitors.
    Zhu L; Cheng P; Lei N; Yao J; Sheng C; Zhuang C; Guo W; Liu W; Zhang Y; Dong G; Wang S; Miao Z; Zhang W
    Arch Pharm (Weinheim); 2011 Nov; 344(11):726-34. PubMed ID: 21956522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacology of camptothecin esters.
    Liehr JG; Harris NJ; Mendoza J; Ahmed AE; Giovanella BC
    Ann N Y Acad Sci; 2000; 922():216-23. PubMed ID: 11193897
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.